D’Arcy v Myriad: Australia’s High Court deals blow to natural product patents
07-10-2015
Africa Studio / Shutterstock.com
The High Court of Australia has revealed it will hear oral arguments in the patent dispute between breast cancer survivor Yvonne D’Arcy and molecular diagnostic company Myriad Genetics on June 16 and 17.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Myriad Genetics, gene patents, Cancer Voices Australia, BRCA, High Court of Australia, IPTA, Institute of Patent and Trade Mark Attorneys of Australia,
